Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Canal

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
L' Orthodontie Francaise|January 1, 1984
[The permanent canine in orthodontics]A Bery, P Canal, F Flageul, et al.
Bulletin Du Cancer|May 1, 1993
[Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers]M de Forni, V Gualano, P Canal, et al.
Nephron|January 1, 1989
Acute renal failure after high-dose methotrexate therapy. Role of hemodialysis and plasma exchange in methotrexate removalF X Thierry, I Vernier, J M Dueymes, et al.
Bulletin Du Cancer|November 1, 1995
[Prediction of carboplatin clearance from morphological and biological patient characteristics]E Chatelut, A Dezeuze, M Lavit, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics of irinotecan and its metabolites in human blood, bile, and urineF Lokiec, P Canal, C Gay, et al.
Cancer Research|October 15, 1993
Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomasP Canal, M Attal, E Chatelut, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 1998
Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4B Monsarrat, E Chatelut, I Royer, et al.
British Journal of Cancer|July 1, 2010
Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma modelJ-P Delord, S Quideau, P Rochaix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studiesE Chatelut, M de Forni, P Canal, et al.
International Journal of Cancer|June 19, 1993
Characterization and chemosensitivity of a human epithelioid sarcoma cell line (SARCCR 2)H Roché, A M Julia, S Jozan, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
L' Orthodontie Francaise|January 1, 1984
[The permanent canine in orthodontics]A Bery, P Canal, F Flageul, et al.
Bulletin Du Cancer|May 1, 1993
[Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers]M de Forni, V Gualano, P Canal, et al.
Nephron|January 1, 1989
Acute renal failure after high-dose methotrexate therapy. Role of hemodialysis and plasma exchange in methotrexate removalF X Thierry, I Vernier, J M Dueymes, et al.
Bulletin Du Cancer|November 1, 1995
[Prediction of carboplatin clearance from morphological and biological patient characteristics]E Chatelut, A Dezeuze, M Lavit, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics of irinotecan and its metabolites in human blood, bile, and urineF Lokiec, P Canal, C Gay, et al.
Cancer Research|October 15, 1993
Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomasP Canal, M Attal, E Chatelut, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 1998
Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4B Monsarrat, E Chatelut, I Royer, et al.
British Journal of Cancer|July 1, 2010
Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma modelJ-P Delord, S Quideau, P Rochaix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
Teniposide and cisplatin given by intraperitoneal administration: preclinical and phase I/pharmacokinetic studiesE Chatelut, M de Forni, P Canal, et al.
International Journal of Cancer|June 19, 1993
Characterization and chemosensitivity of a human epithelioid sarcoma cell line (SARCCR 2)H Roché, A M Julia, S Jozan, et al.
Pageof 15